I
Ikena Oncology D
D
IKNA
1.36500
USD
0.00
(0.00%)
مغلق
حجم التداول
18
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
65,872,322
العنوان: Ikena Oncology
القطاع: Healthcare
الصناعة: Biotechnology
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncologyproduct candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.